CANB Stock Overview
Engages in the production and sale of recreational cannabis and cannabis extracts in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
CanadaBis Capital Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.085 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.035 |
| Beta | 0.45 |
| 1 Month Change | -15.00% |
| 3 Month Change | 41.67% |
| 1 Year Change | 0% |
| 3 Year Change | 112.50% |
| 5 Year Change | -56.41% |
| Change since IPO | -83.33% |
Recent News & Updates
Recent updates
The Market Lifts CanadaBis Capital Inc. (CVE:CANB) Shares 40% But It Can Do More
Mar 03
Further Upside For CanadaBis Capital Inc. (CVE:CANB) Shares Could Introduce Price Risks After 50% Bounce
Jan 17CanadaBis Capital Inc. (CVE:CANB) Not Doing Enough For Some Investors As Its Shares Slump 33%
Dec 03Why Investors Shouldn't Be Surprised By CanadaBis Capital Inc.'s (CVE:CANB) Low P/E
Oct 13We Think CanadaBis Capital (CVE:CANB) Is Taking Some Risk With Its Debt
Aug 19Why Investors Shouldn't Be Surprised By CanadaBis Capital Inc.'s (CVE:CANB) 29% Share Price Plunge
Jul 14CanadaBis Capital (CVE:CANB) Has A Pretty Healthy Balance Sheet
May 09Earnings Working Against CanadaBis Capital Inc.'s (CVE:CANB) Share Price Following 48% Dive
Apr 02If EPS Growth Is Important To You, CanadaBis Capital (CVE:CANB) Presents An Opportunity
Feb 12Is CanadaBis Capital (CVE:CANB) Using Too Much Debt?
Dec 01CanadaBis Capital (CVE:CANB) Seems To Use Debt Quite Sensibly
Jul 17CanadaBis Capital Inc.'s (CVE:CANB) Shares Climb 70% But Its Business Is Yet to Catch Up
Apr 17Auditors Have Doubts About CanadaBis Capital (CVE:CANB)
Dec 01Is CanadaBis Capital (CVE:CANB) A Risky Investment?
Aug 13Is CanadaBis Capital (CVE:CANB) Using Too Much Debt?
Apr 30Is CanadaBis Capital (CVE:CANB) Using Debt Sensibly?
Jan 13Is CanadaBis Capital (CVE:CANB) Using Too Much Debt?
Apr 07Have Insiders Been Selling CanadaBis Capital Inc. (CVE:CANB) Shares This Year?
Feb 14Here's Why CanadaBis Capital (CVE:CANB) Can Afford Some Debt
Dec 23
Shareholder Returns
| CANB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -5.6% | 4.3% | 2.1% |
| 1Y | 0% | -62.7% | 9.0% |
Return vs Industry: CANB exceeded the Canadian Pharmaceuticals industry which returned -62.4% over the past year.
Return vs Market: CANB underperformed the Canadian Market which returned 8.7% over the past year.
Price Volatility
| CANB volatility | |
|---|---|
| CANB Average Weekly Movement | 21.8% |
| Pharmaceuticals Industry Average Movement | 12.3% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 4.0% |
Stable Share Price: CANB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: CANB's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Travis McIntyre | www.canadabis.com |
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: cultivation and wholesale, retail, and extract. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards.
CanadaBis Capital Inc. Fundamentals Summary
| CANB fundamental statistics | |
|---|---|
| Market cap | CA$11.75m |
| Earnings (TTM) | CA$201.75k |
| Revenue (TTM) | CA$17.89m |
58.2x
P/E Ratio0.7x
P/S RatioIs CANB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CANB income statement (TTM) | |
|---|---|
| Revenue | CA$17.89m |
| Cost of Revenue | CA$9.40m |
| Gross Profit | CA$8.50m |
| Other Expenses | CA$8.29m |
| Earnings | CA$201.75k |
Last Reported Earnings
Jan 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0015 |
| Gross Margin | 47.48% |
| Net Profit Margin | 1.13% |
| Debt/Equity Ratio | 67.8% |
How did CANB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/17 02:20 |
| End of Day Share Price | 2025/04/15 00:00 |
| Earnings | 2025/01/31 |
| Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CanadaBis Capital Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.